KLF5, a new player and new target in the permanently changing set of pancreatic cancer molecular drivers

被引：0
|
作者：
M. V. Zinovyeva
M. B. Kostina
I. P. Chernov
L. G. Kondratyeva
E. D. Sverdlov
机构：
[1] Russian Academy of Sciences,Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry
来源：
Russian Journal of Bioorganic Chemistry | 2016年 / 42卷
关键词：
pancreatic ductal adenocarcinoma; KLF5; carcinogenesis; master genes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Pancreatic cancer is one of the most aggressive tumor types characterized by chemotherapy resistance and high metastatic activity. Recent studies revealed new genes, which are likely to be actively involved in the regulation of the processes occurring in the pancreas, as well as in the development of cancer in this organ. This review is devoted to the description of one of the recently revealed genes, KLF5, which seems to be a promising target for therapeutic intervention in the most widespread type of pancreatic cancer, ductal adenocarcinoma.
引用
收藏
页码：606 / 611
页数：5
相关论文
共 50 条
  • [21] Neutrophil Extracellular Traps: A New Player in Cancer Metastasis and Therapeutic Target
    Yang, Dakai
    Liu, Jing
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021, 40 (01)
  • [22] Separase, a key-player of mitosis: A new target for cancer therapy?
    Aouadi, Elyes
    Fornier, Marie
    Gosseye, Axel
    Castillo-Ferrer, Camila
    Frachet, Veronique
    M S-MEDECINE SCIENCES, 2021, 37 (6-7): : 684 - 686
  • [23] New Molecular Player In Colitis and Colitis-Associated Cancer
    Barrett, Kim E.
    CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2025, 19 (03):
  • [24] New Target for Pancreatic Cancer Treatment Shows Potential
    Hampton, Tracy
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (05): : 391 - 392
  • [25] VAV1 - A new target in pancreatic cancer?
    DeNicola, G
    Tuveson, DA
    CANCER BIOLOGY & THERAPY, 2005, 4 (05) : 509 - 511
  • [26] Hhat a Potential New Target in Treatment of Pancreatic Cancer
    Konitsiotis, A.
    Chang, S.
    Masumoto, N.
    Tate, E. W.
    Magee, A. I.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S149 - S149
  • [27] ASAP2, a Downstream of Src Pathway is a Brand New Molecular Target of Pancreatic Cancer
    Fujii, A.
    Masuda, T.
    Kuramitsu, S.
    Kitagawa, A.
    Noda, M.
    Tsuruda, Y.
    Matsumoto, Y.
    Ohtsu, H.
    Uchida, H.
    Ohtsuka, T.
    Nakamura, M.
    Mimori, K.
    PANCREAS, 2019, 48 (10) : 1427 - 1427
  • [28] WWP1, TGF β and KLF5 gene expression levels as new possible factors involved in cervical oncogenesis
    Botezatu, Anca
    Goia-Rusanu, Cristina D.
    Stanescu, Anca D.
    Iancu, Iulia V.
    Popa, Elena
    Nistor, Elena
    Huica, Irina
    Anton, Gabriela
    Plesa, Adriana
    REVISTA ROMANA DE MEDICINA DE LABORATOR, 2011, 19 (01): : 47 - 54
  • [29] ImmunoMet Oncogenesis: A New Concept to Understand the Molecular Drivers of Cancer
    Sirajee, Reshma
    El Khatib, Sami
    Dieleman, Levinus A.
    Salla, Mohamed
    Baksh, Shairaz
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (05)
  • [30] Survivin is a Potential New Therapeutic Target in the Treatment of Pancreatic Cancer
    Ly, Q. P.
    Person, J. J.
    Teggart, C. A.
    Mathiesen, M. R.
    Howell, G. M.
    Brattain, M. G.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S154 - S154
12345